Annotation Detail for FER
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04520 | Adherens junction |
Pathway ID | Pathway Name |
---|
200033 | Signaling events mediated by PTP1B |
200003 | Fc-epsilon receptor I signaling in mast cells |
200156 | Signaling events mediated by Stem cell factor receptor (c-Kit) |
200127 | PDGFR-beta signaling pathway |
200180 | N-cadherin signaling events |
Pathway ID | Pathway Name |
---|
P00012 | Cadherin signaling pathway |
Desease ID | Desease Name |
---|
1848 | Embryoma |
1934 | Cancer |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of FER mRNA | decreases expression | 20106945
|
D008727 |
Methotrexate |
FER protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FER mRNA | affects binding|decreases expression|increases activity | 19710929
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.98 | 12039119 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.64 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.06 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.88 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.22 | 16434500 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.73 | 19183758 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.17 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.63 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.37 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.37 | 16978400 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.14 | 20419170 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.15 | 19176532 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.67 | 12039119 9562676 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.68 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.59 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.71 | 20191521 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.96 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.09 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.25 | 20131406 19236843 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.80 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.85 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.78 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.64 | 19176532 18467677 19772884 16221962 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.63 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.90 | 16306350 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.63 | 9562676 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.91 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.81 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.81 | 20007298 16377806 15890375 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.89 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 20869020 18816296 20064080 18569708 20135361 18520028 17053015 20464547 6695378 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.26 | 17352296 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.53 | 16381670 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
6.02 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.16 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.29 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.29 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.44 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.44 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.89 | 20558911 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.90 | 17292933 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.55 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
5.36 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.56 | 19058328 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.54 | 10029692 19755658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.62 | 9562676 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.31 | 17053015 |
Pathway ID |
Pathway Name |
---|
KEGG:04520 |
Adherens junction |
PharmGKB Accession:PA28095
Releated drug ID |
Related drug Name |
PA10804 | imatinib |